Cargando…
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
Homeodomain-interacting protein kinase 2 (HIPK2) is a multitalented protein that exploits its kinase activity to modulate key molecular pathways in cancer to restrain tumor growth and induce response to therapies. HIPK2 phosphorylates oncosuppressor p53 for apoptotic activation. In addition, also p5...
Autores principales: | D’Orazi, Gabriella, Rinaldo, Cinzia, Soddu, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432601/ https://www.ncbi.nlm.nih.gov/pubmed/22889244 http://dx.doi.org/10.1186/1756-9966-31-63 |
Ejemplares similares
-
The Sweet Side of HIPK2
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 as a Novel Regulator of Fibrosis
por: Garufi, Alessia, et al.
Publicado: (2023) -
Hyperglycemia triggers HIPK2 protein degradation
por: Baldari, Silvia, et al.
Publicado: (2016) -
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
por: Stanga, Serena, et al.
Publicado: (2010)